SEC Form 4 · accession 0001447348-15-000009
PROGENICS PHARMACEUTICALS INC · PGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael D Kishbauch
Director
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 9:55 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000835887
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $6.65 | Mar 2, 2015 | A | 15,342 | A | Mar 2, 2015 | Mar 2, 2025 | Common Stock | 15,342 | 15,342 | D |
Explanation of responses
- F1This stock option becomes exercisable immediately, on the date of grant.